Trials / Unknown
UnknownNCT05412732
Study for the Validation of a New Biomarker to Determine Predisposition to Infections in Patients With Acute Myocardial Infarction.
Study for the Clinical Validation of a New Biomarker to Determine Predisposition to Infections in Patients With Acute Myocardial Infarction.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Instituto de Investigación Hospital Universitario La Paz · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Prospective biomedical research study
Detailed description
The aim is to validate a new biomarker, based on the levels of DNAmit present in blood, to assess the predisposition of an individual to suffer an infection. To validate this hypothesis, the DNAmit levels of patients with myocardial infarction will be analysed and their relationship with the probability of these patients developing an infectious process or not.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | prospective biomedical research study | A prospective biomedical study, in which a comparison will be made of the outcome of a specific disease (in this case, AMI). |
Timeline
- Start date
- 2021-07-21
- Primary completion
- 2022-07-21
- Completion
- 2023-07-21
- First posted
- 2022-06-09
- Last updated
- 2022-06-09
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05412732. Inclusion in this directory is not an endorsement.